Advancing Novel PrEP Products – Alternatives to Non-Inferiority.
- Published in:
- Statistical Communications in Infectious Diseases, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1515/scid-2019-0011
- By:
- Publication type:
- Article
Works matching IS 21946310 AND DT 2019 AND VI 11 AND IP 1
Results: 10
1
2
Crossover and Repeated Randomization in Event Driven Trials for HIV Prevention: Addressing the Impact of Heterogeneity in Risk in the Trial Design.
- Published in:
- Statistical Communications in Infectious Diseases, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1515/scid-2019-0009
- By:
- Publication type:
- Article
3
Current and Future Challenges in Trial Design for Pre-Exposure Prophylaxis in HIV Prevention.
- Published in:
- Statistical Communications in Infectious Diseases, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1515/scid-2019-0008
- By:
- Publication type:
- Article
4
Tomorrow's HIV Prevention Trials of Vaccines and Antibodies.
- Published in:
- Statistical Communications in Infectious Diseases, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1515/scid-2019-0007
- By:
- Publication type:
- Article
5
The Connection between the Averted Infections Ratio and the Rate Ratio in Active-control Trials of Pre-exposure Prophylaxis Agents.
- Published in:
- Statistical Communications in Infectious Diseases, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1515/scid-2019-0006
- By:
- Publication type:
- Article
6
The Modern Randomized Clinical Trial: Is it Time to Sharpen a Blunt Instrument?
- Published in:
- Statistical Communications in Infectious Diseases, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1515/scid-2019-0005
- By:
- Publication type:
- Article
7
Designing the Next Generation of HIV Prevention Efficacy Trials: Synopsis of a 2018 Symposium.
- Published in:
- Statistical Communications in Infectious Diseases, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1515/scid-2019-0004
- By:
- Publication type:
- Article
8
Ongoing Vaccine and Monoclonal Antibody HIV Prevention Efficacy Trials and Considerations for Sequel Efficacy Trial Designs.
- Published in:
- Statistical Communications in Infectious Diseases, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1515/scid-2019-0003
- By:
- Publication type:
- Article
9
Regulatory Perspectives for Streamlining HIV Prevention Trials.
- Published in:
- Statistical Communications in Infectious Diseases, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1515/scid-2019-0002
- By:
- Publication type:
- Article
10
Designing & Conducting Trials to Reliably Evaluate HIV Prevention Interventions.
- Published in:
- Statistical Communications in Infectious Diseases, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1515/scid-2019-0001
- By:
- Publication type:
- Article